Abstract
Preterm infants may pass meconium only after the first 48 hours of life, even in the absence of any gastrointestinal disease. The role of various factors in determining the time of meconium elimination has been recently assessed. Gestational age and start of feeding had been demonstrated to influence first meconium timing. The aim of our study was to evaluate the time of first meconium passage and the time to achieve regular bowel movements (RBM), correlating these two events to different factors such as gestational age (GA), sex, type of delivery [caesarean section (CS) vs spontaneous delivery (SD)], 1 and 5 Apgar score (1AS, 5AS), time and type of feeding, oxygen requirement and any mode of respiratory support.
Keywords: Bowel habit, preterm newborns, first stool passage, meconium, regular bowel movements (RBM)
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title: Bowel Habit in Preterm New borns: Effect of New Formulas
Volume: 10 Issue: 2
Author(s): Mariella Baldassarre, Margherita Fanelli, Anna Maria Laneve, Roberto Grosso, Felicia Varsalone, Maria Rita Falcone, Fabio Russo, Flora Sportelli and Nicola Laforgia
Affiliation:
Keywords: Bowel habit, preterm newborns, first stool passage, meconium, regular bowel movements (RBM)
Abstract: Preterm infants may pass meconium only after the first 48 hours of life, even in the absence of any gastrointestinal disease. The role of various factors in determining the time of meconium elimination has been recently assessed. Gestational age and start of feeding had been demonstrated to influence first meconium timing. The aim of our study was to evaluate the time of first meconium passage and the time to achieve regular bowel movements (RBM), correlating these two events to different factors such as gestational age (GA), sex, type of delivery [caesarean section (CS) vs spontaneous delivery (SD)], 1 and 5 Apgar score (1AS, 5AS), time and type of feeding, oxygen requirement and any mode of respiratory support.
Export Options
About this article
Cite this article as:
Baldassarre Mariella, Fanelli Margherita, Maria Laneve Anna, Grosso Roberto, Varsalone Felicia, Rita Falcone Maria, Russo Fabio, Sportelli Flora and Laforgia Nicola, Bowel Habit in Preterm New borns: Effect of New Formulas, Endocrine, Metabolic & Immune Disorders - Drug Targets 2010; 10 (2) . https://dx.doi.org/10.2174/187153010791213092
DOI https://dx.doi.org/10.2174/187153010791213092 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders
Central Nervous System Agents in Medicinal Chemistry Targeting Mitochondria in Fighting Cancer
Current Pharmaceutical Design Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) The Role of Natural Killer T (NKT) Cells in the Pathogenesis of Type 1 Diabetes
Current Diabetes Reviews Phosphate-Affinity Gel Electrophoresis Using a Phos-Tag Molecule for Phosphoproteome Study
Current Proteomics Determination of three Unsaturated Fatty Acids in Pressure Ulcer Rats Using A UPLC-MS/MS Method
Current Pharmaceutical Analysis Curcumin Targets p53-Fibrinolytic System in TGF-β1 Mediated Alveolar Epithelial Mesenchymal Transition in Alveolar Epithelial Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Incretin-Based Therapy of Type 2 Diabetes Mellitus
Current Protein & Peptide Science Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity
Current Topics in Medicinal Chemistry Inhibitory Effect of Ebselen on Cerebral Acetylcholinesterase Activity In Vitro: Kinetics and Reversibility of Inhibition
Current Pharmaceutical Design Mobile Phone Based Health Care Technology
Recent Patents on Biomedical Engineering (Discontinued) Drug-Associated Mitochondrial Toxicity and its Detection
Current Medicinal Chemistry Obesity, Metabolic Syndrome, Diabetes and Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Is the Autophagy Induced by Thiopurines Beneficial or Deleterious?
Current Drug Metabolism Urinary Exosomal Lipidomics Reveals Markers for Diabetic Nephropathy
Current Metabolomics Growth Factors in the Pathogenesis of Retinal Neurodegeneration in Diabetes Mellitus
Current Neuropharmacology Cognitive Function and the Ageing Process: The Peculiar Role of Mild Thyroid Failure
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Taste and Hypertension in Humans: Targeting Cardiovascular Disease
Current Pharmaceutical Design The Renin-angiotensin System as a Target of Novel Anticancer Therapy
Current Pharmaceutical Design Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery